ÂÜÀòÂÒÂ×

Emmanuelle Deponge has a diverse background in the life sciences industry, with experience ranging from technology transfer to investment management. Currently serving as the CBO at Medetia Pharmaceuticals, Emmanuelle focuses on developing new therapeutics for rare and severe pediatric diseases. Emmanuelle is also involved in mentoring and consulting at TOULINE SAS and serves as a Venture Partner at GO CAPITAL, advising on investments in healthcare sectors. With a strong educational background in biotechnologies and intellectual property, Emmanuelle brings a wealth of knowledge and expertise to their roles in the industry.